Mayo Clinic Finds Gene Expression No Better Than Histology in Prognosing Lung Cancer | GenomeWeb
A Mayo Clinic meta-analysis of published studies shows that gene array-based profiling is no better than conventional histological methods at prognosing lung cancer.
 
“There are many studies currently ongoing using microarrays, but many of them may not be useful clinically,” Zhifu Sun, a research associate in the Department of Health Sciences Research at the Mayo Clinic, told Pharmacogenomics Reporter last week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.